Acute Hyperglycemia Facilitates Contrast-Induced Nephropathy: Independent Risk Marker in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention

Journal of Cardiology & Current Research
doi 10.15406/jccr.2017.10.00351
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

MedCrave Group, LLC

Related search

Mehran and AGEF Risk Scores in Contrast-Induced Nephropathy Among Patients Undergoing Primary Percutaneous Coronary Intervention

The Medical Journal of Cairo University
2018English

Protection Against Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Angiology
Cardiovascular MedicineCardiology
2018English

Relationship Between Serum Procalcitonin Level and Contrast-Induced Nephropathy in Patients Undergoing Primary Percutaneous Coronary Intervention

Turkiye Klinikleri Cardiovascular Sciences
Cardiovascular MedicineCardiology
2016English

Protective Effects of Anisodamine on Contrast Induced Nephropathy in Patients With ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Heart
Cardiovascular MedicineCardiology
2011English

Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention, Iso-Osmolar Non-Ionic Contrast Agent Versus Low-Osmolar Ionic Contrast Agent

Journal of Transcatheter Interventions
2020English

Urinary Interleukin-18 as an Early Indicator to Predict Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2014English

Intracoronary or Intravenous Abciximab After Aspiration Thrombectomy in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention

Cardiovascular Journal of Africa
MedicineCardiovascular MedicineCardiology
2019English

CHADS2-VASC Score as a Predictor for Contrast Induced Nephropathy in Patient With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

The Medical Journal of Cairo University
2019English

Urinary Semaphorin 3A as an Early Biomarker to Predict Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy